Baxion
Screening
Tags
Alerts
Theme
Tango Therapeutics, Inc.
TNGX
·
NASDAQ
·
$20.04
Share Price as of 11/2
·
$2B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/11/26
10-Q
Q1 ended 03/31/26
05/13/26
10-K
FY 2025
03/05/26
10-Q
Q3 ended 09/30/25
11/04/25
10-Q
Q2 ended 06/30/25
08/05/25
Disclosures
Filter
8-K
Current report
10/23/26
8-K
Other Events
08/11/26
8-K
Results of Operations
08/11/26
8-K/A
Change in Directors or Officers; Regulation FD Disclosure
08/07/26
8-K
Change in Directors or Officers
08/06/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
08/11/26
424B5
Prospectus supplement
06/10/26
FWP
Free writing prospectus
06/10/26
424B5
Prospectus supplement
06/08/26
S-8
Registration of securities for employees
03/05/26
Proxies
Filter
DEF 14A
Definitive proxy
04/17/26
DEFA14A
Additional proxy materials
04/17/26
DEFR14A
Definitive proxy (revised)
04/24/25
DEFA14A
Additional proxy materials
04/22/25
DEF 14A
Definitive proxy
04/21/25
Ownership
Filter
Form 4
Insider transaction
10/05/26
Form 4
Insider transaction
09/24/26
144
Proposed sale of securities
09/22/26
Form 4
Insider transaction
09/03/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
ARS
Annual report to shareholders
04/17/26
EFFECT
Request for effectiveness
12/10/25
CORRESP
Correspondence with the SEC
12/08/25
D
D
10/28/25
EFFECT
Request for effectiveness
05/21/25
Latest Filings
Filter
8-K
Current report
10/23/26
10-Q
Q2 ended 06/30/26
08/11/26
8-K
Other Events
08/11/26
8-K
Results of Operations
08/11/26
424B5
Prospectus supplement
08/11/26
Ownership
Filter
Form 4
Insider transaction
10/05/26
Form 4
Insider transaction
09/24/26
144
Proposed sale of securities
09/22/26
Form 4
Insider transaction
09/03/26
SC 13G/A
Beneficial ownership (amended)
08/14/26